Genomic imprinting is essential for mammalian development. Dysregulation of imprinting genes can lead to cancer, diabetes, cardiovascular diseases and other kinds of human diseases. Although genomic imprinting was identified in mammals almost three decades ago, it is still unclear if genomic imprinting plays a role in late embryonic development. Many unanswered questions persist about the nature of genomic imprinting memory and about how genomic imprints are established and maintained. This proposal aims to uncover the underlying molecular mechanisms of establishment, maintenance and acquisition of DNA methylation imprints in mouse embryos and in cell culture. These objectives can be reached now because we have discovered an important regulator in DNA methylation imprints. Our preliminary results indicate that ZFP57 appears to be required for cardiovascular development. ZFP57 can target DNA methyltransferases to imprinting control regions to initiate and maintain DNA methylation imprints. Our proposed experiments will examine whether ZFP57 regulates LIN-12/Notch signaling in cardiovascular development via its target imprinted gene, thereby linking genomic imprinting to late stages of embryonic development. The expected outcome from this research will further our understanding of the establishment and maintenance of DNA methylation imprints, setting the stage for future studies to unravel the molecular nature of genomic imprinting memory. Successful completion of these experiments will also provide proof of principle for manipulating DNA methylation imprints in pluripotent stem cells for future therapeutic applications.

Public Health Relevance

Dysregulation of genomic imprinting are associated with a variety of human diseases including metabolic diseases, cardiovascular diseases and cancer. Indeed, it was just published that mutations in human Zfp57 result in hypomethylation at multiple imprinted regions and are associated with transient neonatal diabetes and congenital heart defects.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Development - 2 Study Section (DEV2)
Program Officer
Carter, Anthony D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Icahn School of Medicine at Mount Sinai
Schools of Medicine
New York
United States
Zip Code
Lau, Ho-Tak; Liu, Lizhi; Li, Xiajun (2016) Zfp57 mutant ES cell lines directly derived from blastocysts. Stem Cell Res 16:282-6
Lau, Ho-Tak; Liu, Lizhi; Ray, Chelsea et al. (2016) Derivation of hybrid ES cell lines from two different strains of mice. Stem Cell Res 16:252-5
McDonald, Carol M; Liu, Lizhi; Xiao, Lijuan et al. (2016) Genomic imprinting defect in Zfp57 mutant iPS cell lines. Stem Cell Res 16:259-63
Shamis, Yulia; Cullen, Dana E; Liu, Lizhi et al. (2015) Maternal and zygotic Zfp57 modulate NOTCH signaling in cardiac development. Proc Natl Acad Sci U S A 112:E2020-9
Liu, Lizhi; Mao, Shi-Qing; Ray, Chelsea et al. (2015) Differential regulation of genomic imprinting by TET proteins in embryonic stem cells. Stem Cell Res 15:435-43
Li, Xiajun (2013) Genomic imprinting is a parental effect established in mammalian germ cells. Curr Top Dev Biol 102:35-59
Takikawa, Sachiko; Ray, Chelsea; Wang, Xin et al. (2013) Genomic imprinting is variably lost during reprogramming of mouse iPS cells. Stem Cell Res 11:861-73
Takikawa, Sachiko; Wang, Xin; Ray, Chelsea et al. (2013) Human and mouse ZFP57 proteins are functionally interchangeable in maintaining genomic imprinting at multiple imprinted regions in mouse ES cells. Epigenetics 8:1268-79
Zuo, Xiaopan; Sheng, Jipo; Lau, Ho-Tak et al. (2012) Zinc finger protein ZFP57 requires its co-factor to recruit DNA methyltransferases and maintains DNA methylation imprint in embryonic stem cells via its transcriptional repression domain. J Biol Chem 287:2107-18